Serum Institute Of India Planning To Manufacture Experimental Ebola Vaccine For Use In Trials Against Outbreak In Uganda

Reuters (10/17, Ross) reports, “The Serum Institute of India plans to manufacture 20,000 to 30,000 doses of an experimental Ebola vaccine by the end of November for use in trials against an outbreak in Uganda, its developers and a company source said,” no...